Skip to content

Clinical trials

Phase 3 Stroke trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Germany Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20056
20065
20071
20083
20091
20103
20112
20123
20136
20143
20162
20171
20183
20192
20201
20212
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated10
Recruiting5
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
AstraZeneca3
Boehringer Ingelheim3
Novartis Pharmaceuticals3
Apurano Pharmaceuticals GmbH2
Janssen Research & Development, LLC2
NoNO Inc.2
Pfizer2
PhotoThera, Inc2
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke53
Ischemic Stroke12
Myocardial Infarction12
Cardiovascular Diseases8
Atrial Fibrillation7
Ischemic Attack, Transient7
Heart Diseases4
Thromboembolism4
Thrombosis4
Acute Coronary Syndrome3

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.